je.st
news
Tag: trial
Federal Appeals Court Denies Kmart Trial Over Flooding of Mississippi Store
2015-04-06 21:21:21| Grocery - Topix.net
A federal appeals court has upheld the dismissal of Kmart Corp.'s lawsuit against a shopping center owner for flood damage to one of its stores in Corinth, Miss. Kmart contended it had evidence to support its arguments that property owner Fulton Improvements LLC knew that a neighboring Kroger was built in a floodway and caused water to flood the Kmart store in 2010.
Tags: store
court
trial
federal
Veeva Systems: Five of the World's Top 20 Pharmaceutical Companies Standardise on Veeva Vault eTMF to Manage Clinical Trial Documents Globally
2015-04-03 12:31:14| Industrial Newsroom - All News for Today
BARCELONA, Spain In the news release, "Five of the World's Top 20 Pharmaceutical Companies Standardise on Veeva Vault eTMF to Manage Clinical Trial Documents Globally" issued on 31 Mar 2015 11:03 GMT, by Veeva Systems over PR Newswire, we are advised by a representative of the company that some changes have been...
Tags: top
systems
companies
documents
Onxeo S.A.: Phase II trial results of Validive presented at the ASCO Conference
2015-04-02 18:23:24| Logistics - Topix.net
Regulatory News: Onxeo S.A. , an innovative company specializing in the development of orphan oncology drugs, today announced that Validive phase II clinical trial results have been accepted for a poster presentation at the 2015 Annual Meeting of the American Society of Clinical Oncology . The ASCO annual meeting is a major event in the field of oncology that brings together 30,000 health professionals and updates on the major latest steps and results achieved in oncology worldwide.
Tags: the
results
presented
trial
Therapure Innovations Receives FDA Approval To Proceed With A Phase 1 Clinical Trial Of The Targeted Liver Cancer Therapeutic TBI 302
2015-04-01 08:23:10| drugdiscoveryonline Home Page
Therapure Innovations, a division of Therapure Biopharma Inc., recently announces that the U.S. Food and Drug Administration (FDA) has given the company approval to proceed with a Phase 1 clinical trial of TBI 302, a targeted therapeutic for the treatment of liver cancer
Tags: trial
phase
approval
cancer
Emmaus Life Sciences To Present Phase 3 Sickle Cell Disease Clinical Trial Data
2015-04-01 07:37:14| drugdiscoveryonline Home Page
Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases recently announced that data from the Company’s Phase 3 clinical trial of its pharmaceutical grade L-glutamine (PGLG) treatment for sickle cell anemia and sickle beta-0 thalassemia, will be presented, during the 9th Annual Sickle Cell Disease Research and Educational Symposium and 38th National Sickle Cell Disease Scientific Meeting
Sites : [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] next »